Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
1 report, 1 independent
Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Guardant Health
American biotechnology company
-
Chris Freeman
researcher
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Stock Yards Bancorp, Inc. made filings regarding insider transactions with the Securities and Exchange Commission.
- Micron Technology CEO Sanjay Mehrotra sold company stock via insider transaction and filed required disclosures with the SEC.
- Insider transactions disclosed in legal filings with the SEC involving Applied Materials.
- Insider sales of Krystal Biotech stock were disclosed to the SEC by executives.
- Idaho Power filed required disclosures regarding insider transactions with the Securities and Exchange Commission.